Toronto, Canada, Sept. 01, 2020 ( GLOBE NEWSWIRE - Link ) -- Vielight Inc. is pleased to announce the commencement of a new clinical trial in the USA. In this trial, Vielight Inc. will test the hypothesis that the recovery of patients who recently tested positive for COVID-19 infection may be accelerated by specialized light therapy. [...]
May 2019 : Link A testimonial story, by Christopher Kamrani, about a former football star and Vielight technology recently appeared in The Salt Lake Tribune. We thought that it is an important testimonial that should be heard by as many people as possible. This brief blog post is intended to help to spread the original [...]
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.Vielight2019-05-24T13:12:05-04:00
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation. Toronto, ON, May 22, 2019: Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study [...]